Relevance of total PSA and free PSA prescriptions

被引：1

作者：

Lamy, Pierre-Jean ^{[1
,2
]}

Brouillet, Jean-Paul ^{[3
]}

Bermont, Laurent ^{[4
]}

Fouillet, Guy ^{[5
]}

Loric, Sylvain ^{[6
]}

机构：

[1] Inst Anal Genom Imagenome, Labosud Grp Inovie Montpellier, Montpellier, France

[2] Clin BeauSoleil, Unite Rech Clin, Montpellier, France

[3] CHU Nimes, Dept Biochim, Nimes, France

[4] CHU, Lab Biochim Med, Besancon, France

[5] Lab Oriade Noviale, Grenoble, France

[6] CHU Creteil, AP HP, Serv Biochim Clin & Genet, Creteil, France

来源：

ANNALES DE BIOLOGIE CLINIQUE | 2018年 / 76卷 / 06期

关键词：

cancer; prostate; early detection; PSA; tumor markers; PROSTATE; RATES;

D O I：

10.1684/abc.2018.1392

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

The total PSA testing has been frequently criticized for its effectiveness in the early detection of prostate cancer. These widely resumed in and out of the medical community have led to a decrease in Prescriptions. Recommendations against the use of PSA for screening have been issued in Hance and in most countries. In the US, the significant decline in total PSA use since 2004 has led to an increase in advanced cancer diagnosis, which has led the authorities to back down. The US preventive services task force (USPSTF) now recommends that men between the ages of 55 and 69 make an individual decision about prostate cancer screening with their clinician. The purpose of this work is to summarize the good practices for the use of the total and free PSA with the views of these last data.

引用

页码：659 / 663

页数：5

共 50 条

[1] Intermethod differences in results for total PSA, free PSA, and percentage of free PSA
Slev, Patricia R.
La'ulu, Sonia L.
Roberts, William L.
[J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (06) : 952 - 958
[2] Rates of total and free PSA prescriptions in France (2012-2014)
Tuppin, Philippe
Leboucher, Claire
Peyre-Lanquar, Gabrielle
Lamy, Pierre-Jean
Gabach, Pierre
Rebillard, Xavier
[J]. PRESSE MEDICALE, 2017, 46 (10): : E237 - E247
[3] Age-related free PSA, total PSA and free PSA total PSA ratios: Establishment of reference ranges in Chinese males
Kao, CH
[J]. ANTICANCER RESEARCH, 1997, 17 (2B) : 1361 - 1365
[4] The clinical value of free PSA and total PSA ratio
Dalva, I
Akan, H
Zincirci, C
Bingol, N
[J]. 5TH MEDITERRANEAN CONGRESS OF UROLOGY, 1997, : 19 - 24
[5] Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection
Tanguay, S
Bégin, LR
Elhilali, MM
Behlouli, H
Karakiewicz, PI
Aprikian, AG
[J]. UROLOGY, 2002, 59 (02) : 261 - 265
[6] Serum total PSA and free PSA in breast tumors
Dash P.
Pati S.
Mangaraj M.
Sahu P.K.
Mohapatra P.C.
[J]. Indian Journal of Clinical Biochemistry, 2011, 26 (2) : 182 - 186
[7] Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: Which is clinically effective and when?
Basso, D
Fogar, P
Piva, MG
Navaglia, F
Mazza, S
Prayer-Galetti, T
Castellucci, E
Pagano, F
Plebani, M
[J]. UROLOGY, 2000, 55 (05) : 710 - 715
[8] Intermethod differences in total PSA and percent free PSA results
La'ulu, S. L.
Roberts, W. L.
[J]. CLINICAL CHEMISTRY, 2007, 53 (06) : A116 - A116
[9] Evaluation of the Hybritech free (PSA-f) and total PSA (PSA-t)
Schwartz, MK
Smith, C
Schwartz, D
Dnistrian, A
Fair, W
Fleshner, N
Scher, H
[J]. CLINICAL CHEMISTRY, 1996, 42 (06) : 686 - 686
[10] Afssaps market survey of total PSA, free PSA and complexed PSA assay kits
[J]. PROGRES EN UROLOGIE, 2007, 17 (02): : 176 - 176

← 1 2 3 4 5 →